Antifungals in gynaecology: focus on terconazole. Rationale for single-dose therapy

Gynakologische Rundschau · 1985 · vol. 25 Suppl 1 , pp. 114–7 · PMID:4007620 · W4302349432
Other OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-13 ⓘ

This paper discusses the rationale for single-dose terconazole therapy in gynecology, specifically focusing on its application as an antifungal treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Candidiasis, Vulvovaginal Triazoles Candidiasis, Vulvovaginal Drug Administration Schedule Female Humans Pregnancy Triazoles

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:48:21.553284+00:00
License: CC0 · commercial use OK